Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antithrombin III Supplementation for Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass.

NCT01698567 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT01698567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01698567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antithrombin III Supplementation for Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Lead sponsor
University of Rochester
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2012
Completion date
March 31, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease